ADHD is the most common childhood psychiatric disorder, affecting behavior and daily functioning in 5 to 7 percent of school-aged children in the United States.
Treatment usually includes:
Behavioral therapy: Traditional approaches to parent behavior therapy and classroom management rely on consistently rewarding desirable behavior and removing rewards for inappropriate behavior.
Medication: Stimulants have long been used to treat ADHD. However, 20 percent of children receive no benefit from these drugs or suffer side effects that limit their use. Nonstimulant medications may also be helpful.
Novel treatment: New treatments are being tested routinely at the MIND Institute and other centers. We will post more information soon on nonpharmacological treatments.
From recognizing symptoms to evaluating treatment options, raising awareness about ADHD and related disorders is the key to early diagnosis and effective treatment. The AIR Program strives to serve as an information and training resource for the community. By participating and contributing to research you can help the MIND Institute find new ways to prevent, better understand and treat ADHD symptoms.
MIND researchers are using neuroimaging studies to better characterize abnormalities of brain function and circuitry associated with ADHD. We use functional neuroimaging (fMRI) and diffusion tensor imaging (DTI) in combination with measures of academic performance and clinical measures (e.g., rating scales) to assess how the brains of persons with ADHD may differ from their peers. Some of our findings have revealed:
The clinical and research activities of the AIR Program are funded through philanthropic, local and government grants. Your support will help us reach our goals faster. To donate, please go to the UC Davis Health's Online Donation Form and designate “ADHD – UC Davis MIND Institute” in the “special instructions for this gift”.